CONGENITAL MYASTHENIC SYNDROME

CONGENITAL MYASTHENIC SYNDROME was reported 21 times

CONGENITAL MYASTHENIC SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Human Immunoglobulin G [EPC] 2 0.0001
1 Purine Antimetabolite [EPC] 2 0.0000
2 Fluoroquinolone Antibacterial [EPC] 1 0.0000
3 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
4 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
5 Corticosteroid [EPC] 4 0.0000
6 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
7 Loop Diuretic [EPC] 1 0.0000
8 Tumor Necrosis Factor Blocker [EPC] 1 0.0000